SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-120760
Filing Date
2023-11-22
Accepted
2023-11-22 16:21:13
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2331305d8_4a.html 4/A  
1 OWNERSHIP DOCUMENT tm2331305d8_4a.xml 4/A 3483
  Complete submission text file 0001104659-23-120760.txt   4924
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORGANOGENESIS INC., 85 DAN ROAD CANTON MA 02021
Business Address
Hagopian Henry III (Reporting) CIK: 0001821822 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39202 | Film No.: 231433768